Home > Products > EGFR & MET
> Recombinant Anti-EGFR x Anti-MET Bispecific Antibody (scFv4-Ig)
Recombinant Anti-EGFR x Anti-MET Bispecific Antibody (scFv4-Ig) (CAT#: FVTIG-154)
Recombinant Anti-EGFR x Anti-MET Bispecific Antibody (scFv4-Ig) is an appended IgG format, which includes four scFv moieties at the N-termini of the constant regions. It is a bivalent homodimer, in which one anti-EGFR scFv is fused to the CH1 domain of a heavy chain and another anti-MET scFv to the CL domain of a light chain, or vice versa. The resulting leads to 2+2 antigen-binding valency. This BsAb can bind and inactivate two receptors simultaneously. It is designed for the research of Colorectal cancer; Pancreatic cancer; Head and neck cancer; Non-small cell lung cancer (NSCLC) therapy.
There are currently no customer reviews or questions for Recombinant Anti-EGFR x Anti-MET Bispecific Antibody (scFv4-Ig) (FVTIG-154). Click the button below to contact us or submit your feedback about this product.